Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February

Alpha Teknova, Inc. (NASDAQ:TKNO) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 964,000 shares, an increase of 54.3% from the January 31st total of 624,800 shares. Approximately 9.1% of the shares of the stock are sold short. Based on an average daily volume of 278,000 shares, the short-interest ratio is currently 3.5 days.

Analyst Upgrades and Downgrades

Separately, Craig Hallum began coverage on Alpha Teknova in a report on Monday, February 10th. They issued a “buy” rating and a $12.00 target price on the stock.

Hedge Funds Weigh In On Alpha Teknova

Institutional investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. grew its stake in shares of Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company’s stock worth $37,000 after buying an additional 3,791 shares during the last quarter. Mount Lucas Management LP bought a new stake in Alpha Teknova during the 4th quarter worth $75,000. China Universal Asset Management Co. Ltd. bought a new stake in Alpha Teknova during the 4th quarter worth $94,000. Two Sigma Investments LP increased its holdings in Alpha Teknova by 46.2% in the 4th quarter. Two Sigma Investments LP now owns 15,148 shares of the company’s stock worth $126,000 after purchasing an additional 4,789 shares in the last quarter. Finally, NewEdge Advisors LLC raised its position in Alpha Teknova by 14.3% in the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company’s stock valued at $131,000 after purchasing an additional 1,953 shares during the last quarter. 13.81% of the stock is currently owned by institutional investors and hedge funds.

Alpha Teknova Stock Down 9.8 %

TKNO stock opened at $5.86 on Tuesday. The firm has a 50-day moving average price of $8.32 and a 200-day moving average price of $6.88. Alpha Teknova has a 12 month low of $1.16 and a 12 month high of $10.37. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $312.38 million, a P/E ratio of -7.92 and a beta of 0.34.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.